Zimmer Biomet Holdings Inc (ZBH)
NYSE · Healthcare · Medical Devices
Zimmer Biomet Holdings Inc is a Healthcare company with a market capitalization of $18.76B, a trailing P/E ratio of 23.9, and a dividend yield of 0.72%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 28, 2026 | $2.09 | $1.86 | +12.4% |
| Q4 2025 | February 10, 2026 | $2.42 | $2.40 | +0.8% |
| Q3 2025 | November 5, 2025 | $1.90 | $1.88 | +1.1% |
| Q2 2025 | August 7, 2025 | $2.07 | $1.98 | +4.5% |
| Q1 2025 | May 5, 2025 | $1.81 | $1.77 | +2.3% |
| Q4 2024 | February 6, 2025 | $2.31 | $2.29 | +0.9% |
Short Interest
FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.
| Settlement | Shares Short | % of Shares Out | Days to Cover | Change |
|---|---|---|---|---|
| July 15, 2026 | 12,054,804 | 6.16% | 5.2 | +2.0% |
| June 30, 2026 | 11,817,407 | 6.04% | 4.6 | +1.1% |
| June 15, 2026 | 11,684,703 | 5.97% | 5.8 | +34.0% |
| May 29, 2026 | 8,717,891 | 4.45% | 3.8 | -4.9% |
| May 15, 2026 | 9,163,593 | 4.68% | 4.1 | -8.3% |
| April 30, 2026 | 9,996,758 | 5.11% | 3.2 | -0.9% |
| April 15, 2026 | 10,086,123 | 5.09% | 5.1 | +0.8% |
| March 31, 2026 | 10,000,836 | 5.05% | 5.1 | +24.8% |
Other Medical Devices Stocks
Frequently Asked Questions
What is Zimmer Biomet Holdings Inc's market cap?
As of August 13, 2026, Zimmer Biomet Holdings Inc (ZBH) has a market capitalization of $18.76B.
What is Zimmer Biomet Holdings Inc's P/E ratio?
Zimmer Biomet Holdings Inc trades at a trailing price-to-earnings (P/E) ratio of 23.9. Its forward P/E is 11.8.
Does Zimmer Biomet Holdings Inc pay a dividend?
Yes — Zimmer Biomet Holdings Inc pays a dividend yielding 0.72%, an annual payout of $0.96 per share.
What sector is ZBH in?
Zimmer Biomet Holdings Inc is in the Healthcare sector, specifically the Medical Devices industry.
What is Zimmer Biomet Holdings Inc's short interest?
As of the July 15, 2026 FINRA settlement, 12,054,804 ZBH shares were sold short, or 6.16% of shares outstanding. Days to cover: 5.2. FINRA publishes short interest twice a month, about nine business days after each settlement date.
What was Zimmer Biomet Holdings Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), Zimmer Biomet Holdings Inc reported revenue of $8.23B and net income of $705.20M.
Ask your own questions about ZBH
Try mrmarket.ai freeData as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.